Status:
COMPLETED
Comparison Between Quadruple Regimens for Helicobacter Pylori Infection in Egypt
Lead Sponsor:
Ayman Magd Eldin Mohammad Sadek
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The overall prevalence of H. Pylori in the developing countries is 50.8%, with the highest one presented in Africa (79.1%). Hybrid therapy is supposed to be more effective as a first-line regimen for ...
Detailed Description
Introduction: Although the decreasing prevalence of Helicobacter Pylori (H. Pylori) worldwide, it remains high in developing countries. According to the most recent studies, the overall prevalence of...
Eligibility Criteria
Inclusion
- Positive Helicobacter pylori antigen in the stool
- Treatment-naive
Exclusion
- Previous treatment for Helicobacter pylori
- Drug hypersensitivity
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT04039412
Start Date
June 1 2018
End Date
June 30 2019
Last Update
November 26 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Human Medicine, Zagazig University
Zagazig, Sharqia Province, Egypt, 44519